Examining additive risk for cerebrovascular dysfunction in a novel late‐onset Alzheimer’s disease model
MODEL-AD continues to create strains that develop endophenotypes of LOAD for preclinical testing. Ultimately, this work will aid in the identification of novel therapeutic approaches that reduce cerebrovascular pathology in ADRDs.
Authors
- Kevin P. Kotredes (ORCID: https://orcid.org/0000-0001-7874-4139)
- Gareth R. Howell (ORCID: https://orcid.org/0000-0003-0565-6474)
- Travis Cossette (ORCID: https://orcid.org/0000-0003-0398-5047)
- Rita O’Rourke
- Alaina M. Reagan (ORCID: https://orcid.org/0000-0001-9666-0879)
- Sarah E. Herrick (ORCID: https://orcid.org/0000-0002-9085-5664)
- Michael Sasner (ORCID: https://orcid.org/0000-0002-6612-6111)
Institutions
- Tufts University (US)
- Jackson Laboratory (US)
- University of Maine (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.092553
- Primary Topic
- Folate and B Vitamins Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00